Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3699106018 | Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699107010 | Lidocaine hydrochloride 20 mg/2 mL and methylprednisolone acetate 80 mg/2 mL suspension for injection vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength denominator unit | Milliliter (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength denominator unit (attribute) | Milliliter (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | est un(e) (attribut) | Product containing methylprednisolone in parenteral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | a une forme pharmaceutique (attribut) | suspension injectable | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | est un(e) (attribut) | Lidocaine-containing product in parenteral dose form | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength denominator unit | Milliliter (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength denominator value | deux | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | est un(e) (attribut) | Product containing lidocaine and methylprednisolone (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength denominator value | deux | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength denominator unit (attribute) | Milliliter (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength numerator value (attribute) | 80 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has presentation strength numerator value (attribute) | 20 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength numerator value (attribute) | 40 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has precise active ingredient | Lidocaine hydrochloride | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has concentration strength numerator value (attribute) | dix | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has basis of strength substance (attribute) | Lidocaine hydrochloride | false | Inferred relationship | Some | 2 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has precise active ingredient | Methylprednisolone acetate | false | Inferred relationship | Some | 1 | |
| Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug) | Has basis of strength substance (attribute) | Methylprednisolone acetate | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR